Global war fears, oil volatility, and geopolitical tensions are shaking stock markets in 2026. While most investors panic during uncertain times, institutional investors are quietly rotating capital into stocks and sectors with stable earnings, strong cash flows, and long-term demand.
Right now, pharma and telecom stocks are emerging as two of the biggest beneficiaries of this capital rotation.
In this blog, we break down:
Every few years, oil turns into the market’s worst nightmare. The news is full of stories about supply cuts, geopolitical shocks, and uncertain demand from China. Every time this happens, small investors go into a panic mode, seeing energy ETFs lose value and thinking the whole market is going to crash.
But experienced investors know a very important fact: when one sector is in trouble, it’s often a good time to invest in another. Even though changes in the price of oil hurt energy stocks and economies that depend on commodities, capital doesn’t go away; it moves around.
Most retail investors react after headlines become mainstream. Institutional investors usually move much earlier. By the time television debates start discussing “safe sectors,” large funds have often already built positions quietly in sectors showing stronger earnings visibility and defensive characteristics.
As of now, it’s mostly going to drug companies and telecom companies.
The Oil Panic Is Real, But It’s Not the Whole Story
Recent changes in the price of oil are caused by a familiar mix of factors: OPEC’s decisions about production, China’s slowing industrial demand, and the fast-moving energy transition that will put long-term pressure on crude prices. It’s been a rough few months for oil-heavy portfolio managers. Brent crude prices have gone up and down a lot, and earnings in the energy sector are being revised downwards.
While the financial media is fixated on oil prices, institutional money is quietly doing what it always does during storms: moving toward clear earnings, stable dividends, and long-term growth. That search takes you straight to telecom and pharmaceuticals.
Why Defensive Sector Stocks Perform Better During War
During geopolitical uncertainty, investors usually move away from cyclical sectors and into defensive sectors that can continue generating revenue regardless of oil prices, inflation, or economic slowdown.
Historically, sectors like pharmaceuticals and telecom have shown stronger resilience during periods of market volatility because they provide essential services with recurring demand.
This is exactly why institutional investors are increasing exposure to these sectors in 2026.
Defence Stocks in India
Defence stocks are shares of companies involved in manufacturing military equipment, aerospace systems, naval platforms, electronics, missiles, and defence technologies. Rising geopolitical tensions and increasing defence budgets are driving investor attention toward this sector in 2026.
| Stock | Focus Area | Why Watch in a Crisis |
|---|---|---|
|
Hindustan Aeronautics Ltd
HAL • NSE
|
Aircraft, helicopters, aero-engines | Largest defence order book in India; direct beneficiary of aircraft maintenance, spares, and fresh procurement cycles. |
|
Bharat Electronics Ltd
BEL • NSE
|
Radars, EW systems, communications | Rising demand for electronic warfare systems and defence electronics during geopolitical conflicts. |
|
Bharat Dynamics Ltd
BDL • NSE
|
Missiles, torpedoes, guided munitions | Key supplier for missile systems and air-defence programs; defence demand accelerates during wartime conditions. |
|
Mazagon Dock Shipbuilders
MAZDOCK • NSE
|
Naval warships, submarines | Strong naval order pipeline with increasing focus on maritime defence and submarine expansion. |
|
Bharat Forge
BHARATFORG • NSE
|
Artillery, armoured vehicles, defence systems | Private-sector defence leader benefiting from exports and rapid defence manufacturing capabilities. |
|
BEML
BEML • NSE
|
Military vehicles, logistics equipment | Demand can rise sharply for military logistics and engineering equipment during periods of conflict. |
|
Zen Technologies
ZENTEC • NSE
|
Combat simulators, defence training | Defence simulation and combat training demand increases as military modernization accelerates globally. |
|
Paras Defence
PARAS • NSE
|
Defence optics, electronics | Niche defence technology company focused on optics, electronics, and advanced defence systems. |
Why Pharma Stocks Are the Quiet Winners
One huge structural advantage for pharmaceutical companies is that demand doesn’t change much. People still need medicine even though the price of oil has dropped. Because prices are high, they don’t put off chemotherapy. This makes drugs one of the safest places to put your money when the economy is bad.
Aside from being defensive, the story of the pipeline is interesting. GLP-1 drugs for diabetes and obesity are changing markets worth billions of dollars. AI-assisted drug discovery is cutting the time it takes to make new drugs from decades to years. A world population that is getting older, especially in the U.S., Europe, and Japan, will ensure steady demand growth for the next twenty years.
Indian pharmaceutical companies are also benefiting from the global “China + 1” manufacturing shift, where multinational healthcare companies are reducing dependency on Chinese suppliers and increasing sourcing from India.
This structural trend is strengthening long-term export opportunities for Indian pharma leaders.
Large-cap global pharma stocks like Novo Nordisk, AstraZeneca, and Eli Lilly have remained resilient despite market volatility. In India, companies like Sun Pharma, Cipla, Dr. Reddy’s Laboratories, Divi’s Laboratories, and Lupin are also gaining investor attention because of strong export demand, specialty drug pipelines, and defensive earnings visibility.
Pharma Stocks in India
Pharmaceutical stocks are gaining investor attention in 2026 as global markets navigate geopolitical uncertainty, healthcare demand growth, and supply chain shifts. Indian pharma companies are benefiting from strong domestic demand, export growth, and the global “China + 1” manufacturing trend.
| Stock | Ticker | Why Watch | Geopolitical Sensitivity | Key Catalysts |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | India’s largest pharma company with diversified specialty and global portfolio exposure. | Lower sensitivity due to strong India business and diversified geographic revenue. | Specialty drug launches, acquisitions, and domestic market growth. |
| Dr. Reddy’s Laboratories | DRREDDY | Strong global generics business with growing specialty and immunology pipeline. | Moderate-to-high due to significant US exposure balanced by emerging market operations. | Patent wins, complex generics, biosimilars, and specialty expansion. |
| Cipla | CIPLA | Dominant player in respiratory therapies and chronic healthcare with strong domestic presence. | Low-to-moderate sensitivity as domestic business provides defensive stability. | GLP-1 related launches, India brand growth, and chronic care demand. |
| Divi’s Laboratories | DIVISLAB | Leading API and CDMO supplier with strong global pharmaceutical partnerships. | Lower sensitivity due to global supply chain diversification away from China. | API onshoring demand, CDMO contracts, and export growth opportunities. |
Telecom: The Overlooked Dividend Machine
Very rarely does telecom make the front page. That’s exactly why smart investors love it when markets are crazy. When treasury yields are uncertain and growth stocks are going down in price, a 4–6% dividend yield from a regulated, cash-generating telecom giant looks very good.
The story of the 5G buildout has grown from hype to real money-making infrastructure. Along with global telecom giants like AT&T, Verizon, Deutsche Telekom, and SoftBank, Indian telecom companies such as Bharti Airtel, Reliance Jio (through Reliance Industries), Tata Communications, and Indus Towers are also benefiting from rising 5G adoption and growing digital infrastructure demand.
Also, telecom companies are becoming more and more integrated with AI infrastructure. Telecom backbones are used for edge computing, private 5G networks for logistics and manufacturing, and connecting data centers. What seems like a dull utility is slowly turning into an AI pick-and-shovel game.
Telecom Stocks to Watch During Geopolitical Uncertainty
Telecom companies are becoming critical infrastructure providers in 2026. Rising AI workloads, cloud computing, secure communications, data-center traffic, and government-backed digital infrastructure spending are strengthening the long-term outlook for telecom and network equipment companies globally.
| Stock | Ticker | Geography | Segment | Why Watch | War Sensitivity |
|---|---|---|---|---|---|
| Reliance Jio (via RIL) | RELIANCE (NSE) | India | Telecom Operator | 524M subscribers, 56.2% EBITDA margin, imminent Jio IPO potential, and strong consumer cashflows supporting resilience during market volatility. | Low — limited direct exposure with resilient telecom demand. |
| Bharti Airtel | BHARTIARTL (NSE) | India + Africa | Telecom Operator | Diversified geographic exposure, strong pricing power, defensive cashflows, and trusted supplier positioning. | Low-Medium sensitivity. |
| Tejas Networks | TEJASNET (NSE) | India | Telecom Equipment | Benefits from India’s telecom indigenization push, export opportunities, and China+1 supply-chain diversification. | Low — benefits from geopolitical supply-chain shifts. |
| Ericsson | ERIC (Nasdaq) | Global (Western) | RAN / Network Equipment | Major beneficiary of Huawei/ZTE replacement cycle, secure network demand, and large telecom operator contracts. | Low — geopolitical tensions act as a positive catalyst. |
| Nokia | NOK (NYSE/Helsinki) | Global (Western) | RAN / Optical / AI Infrastructure | Optical networking and AI infrastructure pivot supports resilient hyperscaler and enterprise demand globally. | Low — benefits from trusted vendor positioning. |
| Ciena | CIEN (NYSE) | Global | Optical / Transport | Rising hyperscaler AI traffic and secure optical backhaul demand continue supporting long-term growth potential. | Low — limited China exposure and resilient infrastructure demand. |
What Smart Investors Actually Do Differently
The difference between investors who are panicked and those who are making money is not intelligence but framework. People with a lot of money and institutional investors who use systematic strategies don’t get emotional when they read about oil news. They keep an eye on how funds are moving and which earnings estimates are being raised even though overall market sentiment is falling.
That message is clear right now: changes to pharmaceutical earnings are going in the right direction. The predictions for telecom’s free cash flow are still the same. On the other hand, oil earnings are under a lot of downward pressure. You don’t have to write the playbook yourself; you just have to be able to read it.
You can tell the difference between patient, data-driven capital allocation and portfolio decisions based on noise by this main idea.
You don’t have to guess how much oil will cost. No matter what happens at the pump, you need to know where earnings are easy to see, balance sheets are strong, and dividends can be paid for a long time.
Conclusion
Right now, investors who are making real money aren’t stuck on crude futures. There are sector scans being done, institutional flows being tracked, and positions being built in pharma and telecom while everyone else is freaking out. The strategy isn’t hard to understand, but most investors fail to follow it consistently, without emotion, across hundreds of variables in real time.
And that’s where Jarvis AI comes in. Jarvis Invest AI is designed to give investors a real edge by scanning sectors, spotting changes in momentum, spotting earnings catalysts, and giving investors actionable insights before the story makes it to the mainstream media.
The next rotation has already begun. Jarvis AI always helps you stay on the right side of things.